Skip to main content

Hudson Bay Capital Management LP

Position in ABT — Abbott Laboratories

CIK 1393825 STAMFORD, CT

Position in ABT

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$7,700,250
+$5,820,900 QoQ
Shares Held
75,000
+400.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Sep 30, 2025
CallValue
$7,500,640
CallShares
56,000
PutValue
$7,500,640
PutShares
56,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Hudson Bay Capital Management LP holds $430,330,614 across 19 Medical Devices names. ABT ranks #8 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 ABT
Abbott Laboratories
This page
75,000 $7,700,250

All Filings in ABT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,700,250 75,000
2025-12-31 $1,879,350 15,000
2025-09-30 $7,500,640 56,000
2025-09-30 $7,500,640 56,000
2025-09-30 $707,872 5,285
2025-06-30 $6,664,490 49,000
2025-06-30 $1,458,707 10,725
2025-03-31 $468,652 3,533
2025-03-31 $835,695 6,300
2024-06-30 $4,675,950 45,000
2020-09-30 $544,150 5,000